Edgestream Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$981K Sell
15,622
-30,904
-66% -$2.15M 0.03% 636
2025
Q4
$3.09M Buy
+46,526
New +$3.01M 0.09% 416
2025
Q3
Sell
-47,727
Closed -$4.17M 923
2025
Q2
$4.17M Buy
47,727
+36,369
+320% +$2.85M 0.12% 340
2025
Q1
$776K Sell
11,358
-1,683
-13% -$137K 0.03% 641
2024
Q4
$1.01M Buy
+13,041
New +$966K 0.04% 566
2024
Q1
Sell
-1,761
Closed -$219K 861
2023
Q4
$219K Buy
+1,761
New +$180K 0.02% 776
2022
Q3
Sell
-56,906
Closed -$4.24M 489
2022
Q2
$4.24M Buy
56,906
+36,342
+177% +$3.32M 0.33% 89
2022
Q1
$2.63M Buy
+20,564
New +$2.25M 0.21% 163
2021
Q4
Sell
-4,016
Closed -$549K 497
2021
Q3
$549K Sell
4,016
-5,248
-57% -$662K 0.03% 383
2021
Q2
$989K Sell
9,264
-26,080
-74% -$2.5M 0.06% 294
2021
Q1
$3.18M Buy
35,344
+10,900
+45% +$1.02M 0.18% 199
2020
Q4
$2.26M Buy
+24,444
New +$2.18M 0.11% 221

Other funds holding DXCM

Edgestream Partners's DXCM Position: Q1 2026 in Review

Edgestream Partners reduced its DexCom (DXCM) stake by 66% in Q1 2026, selling an estimated $2.15M and leaving 15,622 shares worth $981K. The position accounts for 0.03% of the portfolio, ranked #636.

Edgestream Partners first reported a position in DXCM in Q4 2020 and has held it in 12 quarters since. The position peaked at $4.24M in Q2 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Edgestream Partners held 15,622 shares of DexCom worth $981K as of Q1 2026.
  • Edgestream Partners sold 30,904 DexCom shares in Q1 2026, an estimated $2.15M.
  • DexCom made up 0.03% of Edgestream Partners's portfolio in Q1 2026, its #636 holding.
  • Edgestream Partners first reported a position in DexCom in Q4 2020 and has held it in 12 quarters since.
  • Edgestream Partners's DexCom position peaked at $4.24M in Q2 2022.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.